Medicines A-Z

Editorial Standards & Review Process

PakVita content is compiled by our editorial team from primary medical sources — DRAP, WHO, BNF, and FDA labels. We do not currently publish individual reviewer bylines. Every page on PakVita cites its primary sources, and every page discloses that our content uses AI-assisted drafting with editorial review. This is our permanent editorial architecture.

Our editorial model

PakVita operates a citation-first editorial model (Path A) combined with a transparent editorial-team byline (Path B). Every medicine page and every blog article ships under the PakVita Editorial Team byline. No individual reviewer profiles, no named bylines — just verifiable primary sources on every page.

This is the same model used by MedlinePlus, NICE, and the WHO essential-medicines database: authority comes from the quality and verifiability of the cited sources, not from individual credentials printed on the page.

Byline on every page: Compiled by the PakVita Editorial Team · AI-assisted drafting with editorial review · Sourced from DRAP, WHO, BNF · Last updated: {date}

Source hierarchy — what we cite on every page

Every medicine page carries a visible Sources section at the bottom with 3–5 real, clickable citations. These same sources are mirrored in machine-readable JSON-LD citation arrays — the form AI engines parse for source verification.

  1. 1
    DRAP Registered Products Database ↗

    Drug Regulatory Authority of Pakistan — the primary Pakistani regulatory anchor for every medicine page.

  2. 2
    WHO Model List of Essential Medicines ↗

    World Health Organization — international essential-medicines reference for uses, dosage, and safety.

  3. 3
    British National Formulary (BNF) ↗

    BMJ Group & Pharmaceutical Press — clinical dosage, interactions, and contraindication data.

  4. 4
    FDA DailyMed ↗

    US National Library of Medicine — official drug labels where applicable.

  5. 5
    Manufacturer Patient Information Leaflets ↗

    Manufacturer-issued PILs for Pakistan-registered brands where available.

How our editorial process works

  1. AI-assisted initial drafts are generated for every medicine and blog article using the source hierarchy above.
  2. A designated editor reads the AI draft end-to-end and verifies each material claim against the cited DRAP, WHO, BNF, or FDA source. If a claim cannot be verified against a primary source, the page does not ship.
  3. Every page carries a visible Sources block (minimum 3 real, clickable citations) and a matching JSON-LD citation array.
  4. A staggered Last updated date is stored per page in frontmatter and rendered on every page — updated only when the page is substantively edited.
  5. Top-trafficked pages are re-checked every 90 days against current DRAP, WHO, and BNF editions.
  6. Substantive corrections are logged publicly on our corrections page.

What we explicitly do not do

  • We do not publish named individual reviewer or writer bylines — our permanent model is the PakVita Editorial Team.
  • We do not fabricate individual medical credentials, PMDC numbers, or doctor headshots.
  • We do not ship AI-drafted content without a human editorial source-verification pass.
  • We do not use rolling "always N days ago" dates — every last-reviewed date is real and persisted in page frontmatter.
  • We do not claim "reviewed by" when no individual review has occurred.

AI assistance disclosure

PakVita uses AI-assisted drafting for initial content generation. Every article and medicine page carries an explicit disclosure: "AI-assisted drafting with editorial review." We do not publish AI-generated content without a human editorial pass against primary sources. This is in full compliance with Google's 2026 guidelines on AI-generated content — which permit AI-assisted drafting where disclosed honestly, and penalise only deception.

Contact

To report a medical inaccuracy, message us on Instagram @pakvitaofficial. Substantive corrections are logged on our corrections page within 5 working days.

Read our full standards in the editorial policy.